ZUG (dpa-AFX) - Following its takeover by private equity investor Cinven, laboratory services provider Synlab must leave the second-line index SDax. The company no longer fulfills the necessary requirements, the Deutsche Börse subsidiary Stoxx announced on Wednesday evening. At the end of May, the majority shareholder announced that it would submit a purchase offer to the remaining shareholders for their shares and remove the company from the stock exchange. According to previous information, Cinven holds around 86 percent of Synlab shares.

The laboratory service provider will be replaced by the pharmaceutical company Medios in the SDax. The changes will take effect on July 15./he/la